BriaCell Therapeutics（BCTX.US）股东结构 - 机构持仓、大股东与内部人士｜长桥证券

© 2026 Longbridge｜服务条款隐私政策

股东类型

公众及其他83.97%
对冲基金7.56%
机构投资者6.37%
个人与内部人士2.10%

主要股东

主要股东最新
股东
Citadel Advisors LLC	7.56%	65.76 万	6.97%	+64.65 万	2026/01/15
Cable Car Capital LLC	2.49%	21.68 万	--	+21.68 万	2026/03/31
Richard Abbe	1.20%	10.40 万	4.33%	+0	2025/07/15
Heights Capital Management, Inc.	1.14%	9.89 万	4.11%	+0	2025/09/30
Sabby Management, LLC	0.85%	7.39 万	0.85%	+7.39 万	2026/03/31
Iridian Asset Management LLC	0.75%	6.50 万	0.15%	+0	2026/06/30
Iroquois Capital Management, LLC	0.64%	5.60 万	2.33%	+0	2025/07/15
William WilliamsCEO, President & Director	0.40%	3.52 万	0.35%	+3.41 万	2026/02/01
Giuseppe Del PrioreChief Medical Officer	0.22%	1.88 万	0.22%	+1.88 万	2026/02/01
LuminArx Capital Management LP	0.17%	1.50 万	--	+1.50 万	2026/03/31
UBS Asset Management AG	0.13%	1.15 万	0.10%	+1.09 万	2026/03/31
Gadi LevinCFO & Corporate Secretary	0.11%	9,438.00	0.11%	+9,420.00	2026/02/01
Miguel Lopez-LagoChief Scientific Officer	0.11%	9,419.00	0.11%	+9,419.00	2026/02/01
3i Fund	0.11%	9,170.00	0.38%	+0	2025/03/31
Jeremy Myung Plambeck	0.05%	4,330.00	0.18%	+0	2025/08/25
FMR LLC	0.04%	3,223.00	--	+3,223.00	2026/05/29
Morgan Stanley	0.03%	3,021.00	0.15%	-480.00	2026/03/31
Jamieson BondarenkoIndependent Chairman of the Board	0.01%	1,132.00	0.03%	+333.00	2026/02/01
National Bank Investments Inc.	<0.01%	802.00	<0.01%	+802.00	2026/03/31
Fédération des caisses Desjardins du Québec	<0.01%	455.00	0.06%	-750.00	2026/03/31